Literature DB >> 24691114

Opposing effects of smoking in ulcerative colitis and Crohn's disease may be explained by differential effects on dendritic cells.

Aito Ueno1, Humberto Jijon, Suzanne Traves, Ronald Chan, Kim Ford, Paul L Beck, Marietta Iacucci, Miriam Fort Gasia, Herman W Barkema, Remo Panaccione, Gilaad G Kaplan, David Proud, Subrata Ghosh.   

Abstract

BACKGROUND: The mechanisms underlying the differential effects of cigarette smoking in patients with Crohn's disease (CD) and ulcerative colitis (UC) remain unknown. Smoking has been demonstrated to be protective in UC, whereas in CD it has been shown to be associated with a more severe course, more frequent relapses, and postoperative recurrence. Dendritic cells (DC) play a critical role in T-cell activation and differentiation. Thus, we examined the effects of in vitro exposure to cigarette smoke extract (CSE) on phenotype/function of DC obtained from patients with UC and CD.
METHODS: Sixty-eight subjects were recruited including 30 patients with CD, 19 patients with UC, and 19 healthy controls. Peripheral blood monocytes were differentiated to DC in presence of IL-4 and granulocyte-macrophage colony-stimulating factor. The influence of CSE on Mo-DC subsets, cytokine expression, and ability to drive T cell proliferation and polarization were examined.
RESULTS: CSE affected DC phenotypes including increases in class-2 major histocompatibility complex and costimulatory molecules and decreases in CXCL10 and CCL3 levels in UC compared with CD samples. Furthermore, CSE also altered DC function resulting in increasing T cell proliferation and Th1 polarization in CD, whereas it increased Foxp3+ T cells and decreased the Th1 subset in UC samples.
CONCLUSIONS: CSE modulates DC phenotype and function in patients with UC leading to increased prevalence of Foxp3+ CD4 T cells, whereas in patients with CD it skews toward Th1 subsets. Differential DC responses to CSE between CD and UC may contribute to the differential effects associated with cigarette smoking status.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24691114     DOI: 10.1097/MIB.0000000000000018

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  12 in total

1.  Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Authors:  M Severs; S J H van Erp; M E van der Valk; M J J Mangen; H H Fidder; M van der Have; A A van Bodegraven; D J de Jong; C J van der Woude; M J L Romberg-Camps; C H M Clemens; J M Jansen; P C van de Meeberg; N Mahmmod; C Y Ponsioen; C Bolwerk; J R Vermeijden; M J Pierik; P D Siersema; M Leenders; A E van der Meulen-de Jong; G Dijkstra; B Oldenburg
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

2.  The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis.

Authors:  Alexandra D Frolkis; Jennifer de Bruyn; Nathalie Jette; Mark Lowerison; Jordan Engbers; William Ghali; James D Lewis; Isabelle Vallerand; Scott Patten; Bertus Eksteen; Cheryl Barnabe; Remo Panaccione; Subrata Ghosh; Samuel Wiebe; Gilaad G Kaplan
Journal:  Clin Transl Gastroenterol       Date:  2016-04-21       Impact factor: 4.488

Review 3.  Care of inflammatory bowel disease patients in remission.

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-10-10

Review 4.  Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn's Disease and Ulcerative Colitis.

Authors:  Loni Berkowitz; Bárbara M Schultz; Geraldyne A Salazar; Catalina Pardo-Roa; Valentina P Sebastián; Manuel M Álvarez-Lobos; Susan M Bueno
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

Review 5.  The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.

Authors:  M Ellen Kuenzig; Jeff Yim; Stephanie Coward; Bertus Eksteen; Cynthia H Seow; Cheryl Barnabe; Herman W Barkema; Mark S Silverberg; Peter L Lakatos; Paul L Beck; Richard Fedorak; Levinus A Dieleman; Karen Madsen; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan
Journal:  EBioMedicine       Date:  2017-06-16       Impact factor: 8.143

Review 6.  Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.

Authors:  Eleonore Fröhlich; Richard Wahl
Journal:  Front Immunol       Date:  2017-05-09       Impact factor: 7.561

Review 7.  Genetics and Pathogenesis of Inflammatory Bowel Disease.

Authors:  Ta-Chiang Liu; Thaddeus S Stappenbeck
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

Review 8.  Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: An Updated Meta-Analysis of Cohort Studies.

Authors:  Wan Feng; Guangxia Chen; Dawei Cai; Song Zhao; Jiafei Cheng; Hong Shen
Journal:  J Am Heart Assoc       Date:  2017-08-02       Impact factor: 5.501

Review 9.  Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases.

Authors:  Alicja Derkacz; Pawel Olczyk; Katarzyna Komosinska-Vassev
Journal:  Dis Markers       Date:  2018-06-11       Impact factor: 3.434

Review 10.  The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease.

Authors:  Steven Nicolaides; Abhinav Vasudevan; Tony Long; Daniel van Langenberg
Journal:  Intest Res       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.